Abstract
Non-alcoholic fatty liver disease (NAFLD) is considered a predominant chronic liver disease worldwide and a component of metabolic syndrome. Due to its relationship with multiple organs, it is extremely complex to precisely define its pathogenesis as well as to set appropriate therapeutic and preventive strategies. Endocrine disruptors (EDCs) in general, and bisphenol A (BPA) in particular, are a heterogeneous group of substances, largely distributed in daily use items, able to interfere with the normal signaling of several hormones that seem to be related to type 2 diabetes mellitus (T2DM), obesity, and other metabolic disorders. It is reasonable to hypothesize a BPA involvement in the pathogenesis and evolution of NAFLD. However, its mechanisms of action as well as its burden in the vicious circle that connects obesity, T2DM, metabolic syndrome, and NAFLD still remain to be completely defined. In this review we analyzed the scientific evidence on this promising research area, in order to provide an overview of the harmful effects linked to the exposure to EDCs as well as to frame the role that BPA would have in all phases of NAFLD evolution.
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference72 articles.
1. Non-alcoholic fatty liver disease
2. Nonobese Fatty Liver Disease. Clinical gastroenterology and hepatology: The official clinical practice;Kim;J. Am. Gastroenterol. Assoc.,2017
3. Human exposure to Bisphenol A and liver health status: Quantification of urinary and circulating levels by LC–MS/MS
4. Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
5. The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: Role of endothelial dysfunction;Federico;Eur. Rev. Med. Pharmacol. Sci.,2016
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献